Latest filings (excl ownership)
CT ORDER
Confidential treatment order
25 May 16
SC TO-I/A
Issuer tender offer statement (amended)
5 Mar 15
15-12G
Securities registration termination
9 Feb 15
SC TO-I/A
Issuer tender offer statement (amended)
4 Feb 15
SC TO-I
Issuer tender offer statement
3 Feb 15
8-K/A
Entry into a Material Definitive Agreement
30 Jan 15
25-NSE
Exchange delisting
29 Jan 15
8-K
Entry into a Material Definitive Agreement
29 Jan 15
EFFECT
Notice of effectiveness
29 Jan 15
EFFECT
Notice of effectiveness
29 Jan 15
EFFECT
Notice of effectiveness
29 Jan 15
EFFECT
Notice of effectiveness
29 Jan 15
POS AM
Prospectus update (post-effective amendment)
29 Jan 15
POS AM
Prospectus update (post-effective amendment)
29 Jan 15
POS AM
Prospectus update (post-effective amendment)
29 Jan 15
POS AM
Prospectus update (post-effective amendment)
29 Jan 15
POSASR
Automatic shelf registration (post-effective amendment)
29 Jan 15
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jan 15
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jan 15
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jan 15
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jan 15
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jan 15
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jan 15
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jan 15
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jan 15
8-K
Auxilium Announces Results from
27 Jan 15
425
Business combination disclosure
21 Jan 15
8-K
Other Events
21 Jan 15
425
Business combination disclosure
20 Jan 15
425
Business combination disclosure
16 Jan 15
8-K
Other Events
16 Jan 15
425
Business combination disclosure
9 Jan 15
425
Business combination disclosure
9 Jan 15
DEFM14A
Proxy related to merger
24 Dec 14
8-K
Sobi’s Xiapex receives positive opinion by CHMP for the treatment of Peyronie’s disease
22 Dec 14
425
Business combination disclosure
19 Dec 14
8-K
Departure of Directors or Certain Officers
19 Dec 14
425
Business combination disclosure
16 Dec 14
425
Business combination disclosure
16 Dec 14
425
Business combination disclosure
16 Dec 14
Latest ownership filings
SC 13G/A
Auxilium Pharmaceuticals Inc
16 Feb 16
SC 13G/A
Auxilium Pharmaceuticals Inc
18 Feb 15
SC 13G
Auxilium Pharmaceuticals Inc
17 Feb 15
SC 13G/A
Auxilium Pharmaceuticals Inc
17 Feb 15
SC 13G/A
Auxilium Pharmaceuticals Inc
13 Feb 15
SC 13G
Auxilium Pharmaceuticals Inc
10 Feb 15
SC 13G/A
Auxilium Pharmaceuticals Inc
10 Feb 15
SC 13G/A
Auxilium Pharmaceuticals Inc
4 Feb 15
SC 13G/A
Auxilium Pharmaceuticals Inc
30 Jan 15
SC 13G/A
Auxilium Pharmaceuticals Inc
26 Jan 15
SC 13G/A
Auxilium Pharmaceuticals Inc
10 Nov 14
SC 13D
QLT INC/BC
7 Jul 14
SC 13G/A
Auxilium Pharmaceuticals Inc
10 Jun 14
SC 13G/A
Auxilium Pharmaceuticals Inc
10 Apr 14
SC 13G
Auxilium Pharmaceuticals Inc
14 Feb 14
SC 13G/A
Auxilium Pharmaceuticals Inc
14 Feb 14
SC 13G/A
Auxilium Pharmaceuticals Inc
14 Feb 14
SC 13G/A
Auxilium Pharmaceuticals Inc
14 Feb 14
SC 13G/A
Auxilium Pharmaceuticals Inc
14 Feb 14
SC 13G/A
Auxilium Pharmaceuticals Inc
14 Feb 14
SC 13G/A
Auxilium Pharmaceuticals Inc
11 Feb 14
SC 13G/A
Auxilium Pharmaceuticals Inc
11 Feb 14
SC 13G
Auxilium Pharmaceuticals Inc
10 Feb 14
SC 13G/A
Auxilium Pharmaceuticals Inc
28 Jan 14
SC 13G
Beneficial ownership report
9 Sep 13